Vistagen Therapeutics (VTGN) Operating Margin Growth (1y) (2012 - 2026)
Vistagen Therapeutics (VTGN) Operating Margin Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 7,666.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1,238.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2,002.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3,558.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 29,091.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -1,651.00 |
| 10 | Vistagen Therapeutics | 10.49 Mn | 10.49 Mn | - | 557,271.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.02 Mn |
| Dec 31, 2025 | 1,071.00 |
| Sep 30, 2025 | 184.00 |
| Jun 30, 2025 | 796,462.00 |
| Mar 31, 2025 | 10.24 Mn |
| Dec 31, 2024 | -454,329.00 |
| Sep 30, 2024 | -551,432.00 |
| Jun 30, 2024 | -1.09 Mn |
| Mar 31, 2024 | 118,799.00 |
| Dec 31, 2023 | 350,759.00 |
| Sep 30, 2023 | -30,151.00 |
| Jun 30, 2023 | 287,736.00 |
| Mar 31, 2023 | 3.58 Mn |
| Dec 31, 2022 | -248,198.00 |
| Sep 30, 2022 | 161,693.00 |
| Jun 30, 2022 | -418,794.00 |
| Mar 31, 2022 | -4.14 Mn |
| Dec 31, 2021 | -125,403.00 |
| Sep 30, 2021 | -258,928.00 |
| Sep 30, 2012 | -41.99 Mn |